Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Hebei Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 22 active clinical trials for multiple myeloma hosted across 9 tertiary medical centers in Hebei (including The Second Hospital of Hebei Medical University, Affiliated Hospital of Chengde Medical University, Affiliated Hospital of North China University of Science and Technology, etc.).
Participating Medical Centers (9)
Active Studies in Hebei (22)
Population synthesized by CMDNShowing 0 published English records of 22 registry trials.
All 22 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.